BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 20684543)

  • 1. Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.
    Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
    Bioconjug Chem; 2010 Sep; 21(9):1662-72. PubMed ID: 20684543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct uptake routes of cell-penetrating peptide conjugates.
    Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
    Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of endocytosis on the uptake kinetics of luciferin-conjugated cell-penetrating peptides.
    Mäger I; Langel K; Lehto T; Eiríksdóttir E; Langel U
    Biochim Biophys Acta; 2012 Mar; 1818(3):502-11. PubMed ID: 22155257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration without cells: membrane translocation of cell-penetrating peptides in the model giant plasma membrane vesicles.
    Säälik P; Niinep A; Pae J; Hansen M; Lubenets D; Langel Ü; Pooga M
    J Control Release; 2011 Jul; 153(2):117-25. PubMed ID: 21420454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery.
    Massodi I; Bidwell GL; Raucher D
    J Control Release; 2005 Nov; 108(2-3):396-408. PubMed ID: 16157413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake kinetics of cell-penetrating peptides.
    Florén A; Mäger I; Langel U
    Methods Mol Biol; 2011; 683():117-28. PubMed ID: 21053126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides.
    Hassane FS; Abes R; El Andaloussi S; Lehto T; Sillard R; Langel U; Lebleu B
    J Control Release; 2011 Jul; 153(2):163-72. PubMed ID: 21536086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of splice correction by cell-penetrating peptide nucleic acids.
    El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
    J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
    Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid wash in determining cellular uptake of Fab/cell-permeating peptide conjugates.
    Kameyama S; Horie M; Kikuchi T; Omura T; Tadokoro A; Takeuchi T; Nakase I; Sugiura Y; Futaki S
    Biopolymers; 2007; 88(2):98-107. PubMed ID: 17252560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internalization of nucleoside phosphates into live cells by complex formation with different CPPs and JBS-nucleoducin.
    Mussbach F; Pietrucha R; Schaefer B; Reissmann S
    Methods Mol Biol; 2011; 683():375-89. PubMed ID: 21053144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of cell-penetrating peptides.
    Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
    Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into cell-entry mechanisms of CPPs by electron microscopy.
    Padari K; Lorents A; Jokitalo E; Pooga M
    Methods Mol Biol; 2011; 683():181-93. PubMed ID: 21053130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creation of a novel cell penetrating peptide, using a random 18mer peptides library.
    Nomura T; Kawamura M; Shibata H; Abe Y; Ohkawa A; Mukai Y; Sugita T; Imai S; Nagano K; Okamoto T; Tsutsumi Y; Kamada H; Nakagawa S; Tsunoda S
    Pharmazie; 2007 Aug; 62(8):569-73. PubMed ID: 17867548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity, Immunogenicity, Uptake, and Kinetics Methods for CPPs.
    Uusna J; Langel K; Langel Ü
    Methods Mol Biol; 2015; 1324():133-48. PubMed ID: 26202267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamics of lipid interactions with cell-penetrating peptides.
    Sauder R; Seelig J; Ziegler A
    Methods Mol Biol; 2011; 683():129-55. PubMed ID: 21053127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
    Guterstam P; Andaloussi SE; Langel U
    Methods Mol Biol; 2011; 683():219-30. PubMed ID: 21053133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization.
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2011; 683():391-7. PubMed ID: 21053145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides.
    Fischer R; Fotin-Mleczek M; Hufnagel H; Brock R
    Chembiochem; 2005 Dec; 6(12):2126-42. PubMed ID: 16254940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.